Equity-Based Compensation |
6 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | ||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||
| Equity-Based Compensation | 4. Equity-Based Compensation We granted 8,984 and 8,521 restricted stock units (RSUs) during the three months ended June 30, 2025 and 2024, respectively, and granted 495,334 and 547,849 RSUs during the six months ended June 30, 2025 and 2024, respectively. Equity-based compensation expense related to RSUs was $24.3 million and $24.7 million during the three months ended June 30, 2025 and 2024, respectively, and $53.1 million and $46.8 million during the six months ended June 30, 2025 and 2024, respectively. We present below a summary of changes during the six months ended June 30, 2025 in our unvested units of restricted stock:
|
|||||||||||||||||||||||||||||||||||